Out to pioneer gene editing in China, EdiGene bags $67M to begin clinical testing for β-thalassemia therapy, universal CAR-T

Time：20-10-13 08:00 Form: Null Views:63

Careers : hr@EdiGene.com
Partnership : bd@EdiGene.com
Media Inquiries : media@EdiGene.com

About Us

Company Overview Scientific Founder Leadership Contact Us

Our Business

Gene Editing Our Pipeline Our Focus

News

Press Releases In the Media

Careers

Company Culture Join Us

Out to pi­o­neer gene edit­ing in Chi­na, Edi­Gene bags $67M to be­gin clin­i­cal test­ing for β-tha­lassemia ther­a­py, uni­ver­sal CAR-T